Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
The veterinary vaccine producer raised a modest $6.9 million in its New York listing by selling just 3% of its shares, as it diversifies into the household pets market Key…
Recent Articles
RELATED ARTICLES
-
Dogness limps ahead as investors chase its stock
DOGZ.US -
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
FAST NEWS: CanSino’s quarterly revenue rises, but loss also widens
6185.HK 688185.SHG
-
China loves cured meat. But will Wing Yip’s satisfy investor palates?
900340.KQ
- BingEx delivers profitable IPO option for U.S. investors
